We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

New Promega NanoBRET™ Technology Enables Real-Time Monitoring of Protein Interactions in Live Cells

Product News   May 05, 2015

 
New Promega NanoBRET™ Technology Enables Real-Time Monitoring of Protein Interactions in Live Cells
FURTHER INFORMATION
 
 
 

Related Product News

Promising Efficacy and Toxicity Data For New Antibody Drug Conjugate

Product News

Femtogenix has announced data verifying the favorable toxicity profile and potent efficacy of its Pyridinobenzodiazepine (PDD) antibody-drug conjugate payload platform in tumor cell models.

READ MORE

Industrial Scale Manufacture of Therapeutic Exosomes

Product News

BIA Separations has announced a new solution to help drug-developers overcome critical development bottlenecks in the preparation of exosomes for clinical use.

READ MORE

Tumor Regression with New Antibody-Drug Conjugate

Product News

Iksuda Therapeutics (Iksuda), a developer of next generation Antibody Drug Conjugates (ADCs), has announced the first data on its lead ADC, IKS01.

READ MORE

Like what you just read? You can find similar content on the communities below.

Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE